L
LogicBio Therapeutics Inc
F:0IF
LogicBio Therapeutics Inc
F:0IF
Price:
2.04
EUR
Market Closed
Market Cap:
€67.2m
Relative Value
The Relative Value of one 0IF stock under the Base Case scenario is hidden EUR. Compared to the current market price of 2.04 EUR, LogicBio Therapeutics Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
0IF Relative Value
HIDDEN
Multiples Across Competitors
0IF Competitors Multiples
LogicBio Therapeutics Inc Competitors
LogicBio Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
L
|
LogicBio Therapeutics Inc
F:0IF
|
67.2m EUR | 1.1 | -10.5 | 2.2 | -295.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
411.5B USD | 6.9 | 175.3 | 16.9 | 24 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
201.1B USD | 5.5 | 26.1 | 14.9 | 14.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
192.5B USD | 6.5 | 22.6 | 15.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.8B USD | 10.1 | 30.6 | 23.4 | 24.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.8B USD | 5.8 | 18.6 | 14.2 | 16.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 14.3 | 33.7 | 57.9 | 59.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
72.9B AUD | 3.3 | 17 | 11.6 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
